Intestinal Failure
32
5
7
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.1%
1 terminated out of 32 trials
93.8%
+7.2% vs benchmark
6%
2 trials in Phase 3/4
0%
0 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (32)
Video Training Supplementation for Patients Discharged on Home Parental Nutrition
CGM-Assisted Management of PN
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
The LIFT-ECHO Last Mile Project
Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients
AI-driven Total Parenteral Nutrition Platform
Chyme Reinfusion for Type 2 Intestinal Failure
Optimised Osmolality in Oral Supplements Optimised Osmolality in Oral Supplements
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure
Risk Factors for Catheter-Related Bloodstream Infections in Hospitalized Intestinal Failure Patients
Effect of Vitamin D on Skeletal Muscle Function and Qol in Patients With Chronic Intestinal Failure/Insufficiency
Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)
Spectral Lighting and Intestinal Failure
Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments
Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections
Weaning is Winning? (WeWin Study)
Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure
Bone Markers in Pediatric IF
8.4% Sodium Bicarbonate Locks in Intestinal Failure